Insulet

Youtube Subscribe

Open: 190.73 Close: 194.02 Change: 3.29

Don't invest before reading what an AI found about Insulet Company Inc Stock.

This document will help you to evaluate Insulet without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Insulet are: Insulet, share, increase, company, price, quarter, Territory, and the …

Concept Map

Semantic Network

Stock Summary

Insulet Corp. (PODD) stock has fallen -4.45% while the S&P 500 has gained 0.25%. Wayde McMillan will step down as the medical device makers chief financial officer.

Today's Summary

Oppenheimer Asset Management Inc. increased its stake in Insulet Co. (NASDAQ:PODD – Get Free Report ) Director Shacey Petrovic sold 20,000 shares of the company in a transaction on Monday, November 13th. Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of$0.00 per share and an increase next year. Shares presently guard:[ GamesIELD detainee operator PearlTONpora Extend

Today's News

Oppenheimer Asset Management Inc. increased its stake in Insulet Co. (NASDAQ:PODD – Get Free Report ) Director Shacey Petrovic sold 20,000 shares of the company in a transaction on Monday, November 13th. The current share price is 23, which is 54% below its historic score. Insulet stock price is 194.02 USD today. Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of$0.00 per share and an increase next year. Abbott sees big opportunities in insulin pump connectivity. Insulet Corp. hiring Territory Manager - Allentown, PA (Field Based) in AllentOWN, Pennsylvania, United States. Responsibilities The Territory Manager is accountable for consistently achieving sales objectives. Insulet is building a brand-new, state-of-the-art manufacturing facility on a 26-acre site in Acton, Massachusetts. The Global Manufacturing Engineering team is focused on supporting Insulets manufacturing operations. Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform.

Stock Profile

" Insulet Corp. said on Tuesday Wayde McMillan would step down as the medical device makers chief financial officer, effective Oct. 3. Insulets accounting chief, Lauren Budden, will assume the additional responsibilities of interim CFO until a permanent successor is appointed. Insulet Corporation (PODD) stock has fallen -4.45% while the S&P 500 has gained 0.25% as of 9:37 AM on Wednesday, Oct 4. Wayde McMillan decided to leave his role as EVP, CFO and treasurer in March 2019. 3M spinoff picks Insulets Wayde McMillan as CFO. 3M CFO Wayde worked for Medtronic. Insulet (PODD) stock will have to gain more than 100% from here. Returning to the pre-inflation shock level of $318 means that PODD stock will need to gain over 100%. Insulets stock price is down 4.23% on the Nasdaq as of Thursday morning, coming in at $145.64 per share. Insulet reaffirmed its previously announced Omnipod revenues and total revenue guidance. Insulet Corporation (PODD) - 8-K - Current report SEC Filings: Insulets announced today that CFO departs for same post at 3Ms Health Care spinoff. Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions."

Keywords

The game is changing. There is a new strategy to evaluate Insulet fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Insulet are: Insulet, share, increase, company, price, quarter, Territory, and the most common words in the summary are: insulet, stock, corporation, news, omnipod, device, company, . One of the sentences in the summary was: Oppenheimer Asset Management Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #insulet #stock #corporation #news #omnipod #device #company.

Read more →

Youtube Subscribe

---